Showing results (1-10 of 86) with videos related to
Sort By:
Pageof 9
Cleveland Clinic Journal of Medicine|March 3, 2025
Psychedelic-assisted therapy: An overview for the internistBrian S Barnett, Erin E Mauney, Franklin KingJournal of Psychoactive Drugs|August 19, 2021
Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory SurveyBrian S Barnett, Yvan Beaussant, Franklin King, et al.Psychedelic Medicine (New Rochelle, N.Y.)|May 14, 2026
Who Keeps Using Lysergic Acid Diethylamide? Correlates of Past-Year Use in People Who Initiated Use at least Five Years AgoBrian S Barnett, Akhil Anand, Jeremy Weleff, et al.Journal of Psychoactive Drugs|July 2, 2025
Psychiatric Residents' Perspectives on Psychedelics and Psychedelic Assisted TherapyBrian S Barnett, Miranda Arakelian, Jeremy Weleff, et al.Journal of Psychiatric Practice|March 25, 2024
Formulary Coverage of Esketamine and Ketamine for Depression in Ohio Health Insurance Marketplace and Medicaid PlansBrian S Barnett, Journal of Psychopharmacology (Oxford, England)|September 16, 2022
Deepening our understanding of psychedelics by expanding psychedelic data collection in the United States National Survey on Drug Use and HealthBrian S BarnettThe Primary Care Companion for CNS Disorders|June 26, 2026
Psychological Adverse Effects of Psychedelic UseFranklin King, Juliana Zambrano, Erin Mauney, et al.The Primary Care Companion for CNS Disorders|June 26, 2026
Medical Complications of PsychedelicsFranklin King, Brian S Barnett, S Trevor Taylor, et al.Psychedelic Medicine (New Rochelle, N.Y.)|March 6, 2025
Psychedelic Medicine's Future Depends on Proactive Development of a Robust Medical Billing and Coding StrategyBrian S Barnett, Andrey OstrovskyJournal of Psychoactive Drugs|November 26, 2020
Dissemination of Erroneous Research Findings and Subsequent Retraction in High-Circulation Newspapers: A Case Study of Alleged MDMA-Induced Dopaminergic Neurotoxicity in PrimatesBrian S Barnett, Richard DoblinPageof 9